Could your phone replace lab tests for muscle disease?

NCT ID NCT07321977

Knowledge-focused Sponsor: Institut de Myologie, France Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether a smartphone app can accurately measure how people walk, without needing special markers or equipment. Researchers will compare the app's measurements to a standard motion-capture system in 30 volunteers—some with neuromuscular diseases like SMA or muscular dystrophy, and some healthy. The goal is to find a simpler way to track disease progression in clinics and future trials.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to: If successful, this could provide a simple, portable way to track disease progression in neuromuscular conditions, aiding future clinical trials.
What could go wrong: This is a small, early-stage observational study (30 participants) focused on measurement accuracy, not treatment. The technology may not prove reliable enough for widespread use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

* All volunteers * Age between 18 and 65 * Ambulatory * Informed consent to participate in the study * Member of or beneficiary of a social security system * Volunteers with a neuromuscular disease * Confirmed diagnosis of a neuromuscular disease of genetic origin (medical document to be provided upon enrollment in the study with proof of diagnosis) belonging to the list above. * Ability to walk for 2 minutes without assistance. * Ability to stand up from a chair with armrests at least 3 times in 30 seconds. * Ability to climb an inclined plane independently or with assistance to access the movement analysis room. Exclusion Criteria * All volunteers * Individuals under guardianship, curatorship, or legal protection * Pregnant or breastfeeding women * Non-ambulatory individuals * Individuals with epilepsy * Skin conditions preventing the placement of VICON motion sensors * Asymptomatic volunteers * Unstable respiratory or cardiac problems * Neurological, musculoskeletal, or psychiatric problems * Volunteers with a neuromuscular disease * Recent trauma or serious falls (≤ 6 months) * Individuals who have fallen more than twice in the past year and at least once in the past three months * Use of assistive devices such as rigid knee braces or walkers * Unstable cardiomyopathy * Individuals awaiting diagnosis Exclusion criteria * Inability to comply with the protocol requirements * Medical or social conditions that could interfere with the study, as determined by the coordinating investigator or co-investigators.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Charcot-Marie-Tooth are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Charcot-Marie-Tooth disease disease muscular dystrophy myotonic dystrophy spinal muscular atrophy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Charcot-Marie-Tooth Muscular dystrophy Myotonic dystrophy Spinal muscular atrophy (SMA)

How to take part

Only the study team decides who joins. These are the ways to reach them.

The places running it

1 site. The list below names each one and where it is.
The official record

ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

Open the record ↗
A doctor treating you

A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Could your phone replace lab tests for muscle disease?

What the study statuses mean